Affiliations 

  • 1 Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands
  • 2 Department of Neurology, University Hospital St-Luc, Brussels, Belgium
  • 3 Department of Neurology, King's College Hospital, London, UK
  • 4 Department of Neurology, University of Malaya, Kuala Lumpur, Malaysia
  • 5 Department of Neurology, The University of Kansas Medical Center, Kansas City, Kansas, USA
  • 6 Department of Neurology, Hospital Universitario Infanta Sofia, San Sebastian, Spain
  • 7 Department of Neurology, Toronto General Hospital, University Health Network, Toronto, Canada
  • 8 Clinical Neurophysiology, Department of Neurology, The Royal Melbourne Hospital, Parkville, Australia
  • 9 Department of Neurology, University Hospital of Cologne, Cologne, Germany
  • 10 Department of Clinical Neurophysiology, Reference Centre for Neuromuscular Disorders AOC, Filnemus, Euro-NMD, University of Nantes, Nantes, France
  • 11 Department of Neurology, Hospital Británico, Buenos Aires, Argentina
  • 12 Department of Neuroscience, Imaging and Clinical Sciences, University "G. D'Annunzio", Chieti, Italy
  • 13 Department of Neurology, Amsterdam Neuroscience, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
  • 14 Department of Neurology, University of Vermont Medical Centre, Burlington, Vermont, USA
  • 15 Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA
J Peripher Nerv Syst, 2022 Sep;27(3):197-205.
PMID: 35700346 DOI: 10.1111/jns.12504

Abstract

Electrodiagnostic (EDx) studies are helpful in diagnosing and subtyping of Guillain-Barré syndrome (GBS). Published criteria for differentiation into GBS subtypes focus on cutoff values, but other items receive less attention, although they may influence EDx subtyping: (a) extensiveness of EDx testing, (b) nerve-specific considerations, (c) distal compound muscle action potential (CMAP)-amplitude requirements, (d) criteria for conduction block and temporal dispersion. The aims of this study were to investigate how these aspects were approached by neuromuscular EDx experts in practice and how this was done in previously published EDx criteria for GBS. A completed questionnaire was returned by 24 (of 49) members of the electrophysiology expertise group from the International GBS Outcome Study. Six published EDx criteria for GBS subtyping were compared regarding these aspects. The indicated minimal number of motor nerves to study varied among respondents and tended to be more extensive in equivocal than normal studies. Respondents varied considerably regarding usage of compression sites for subtyping (median/wrist, ulnar/elbow, peroneal/fibular head): 29% used all variables from all sites, 13% excluded all sites, and 58% used only some sites and/or variables. Thirty-eight percent of respondents required a minimal distal CMAP amplitude to classify distal motor latency as demyelinating, and 58% did for motor conduction velocity. For proximal/distal CMAP-amplitude ratio and F-wave latency, a requisite minimal CMAP amplitude was more often required (79%). Also, the various published criteria sets showed differences on all items. Practical use of EDx criteria for subtyping GBS vary extensively across respondents, potentially lowering the reproducibility of GBS subtyping.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.